Consolidated Balance Sheets - USD ($) $ in Thousands	Jan. 03, 2021	Dec. 29, 2019
Current assets:
Cash and cash equivalents	$ 402,036	$ 191,877
Accounts receivable, net	1,155,109	725,184
Inventories	514,567	356,937
Other current assets	167,208	100,381
Total current assets	2,238,920	1,374,379
Property, plant and equipment, net	368,304	318,223
Operating Lease, Right-of-Use Asset	207,236	167,276
Intangible assets, net	1,365,693	1,283,286
Goodwill	3,447,114	3,111,227
Other assets, net	333,048	284,173
Total assets	7,960,315	6,538,564
Current liabilities:
Current portion of long-term debt	380,948	9,974
Accounts payable	327,325	235,855
Accrued restructuring and contract termination costs	4,716	11,559
Accrued expenses and other current liabilities	937,027	503,332
Current liabilities of discontinued operations	2,173	2,112
Total current liabilities	1,652,189	762,832
Long-term debt	1,609,701	2,064,041
Long-term liabilities	774,531	751,468
Operating Lease, Liability, Noncurrent	188,402	146,399
Total liabilities	4,224,823	3,724,740
Commitments and contingencies (see Notes 14 and 17)
Stockholders' equity:
Preferred stock—$1 par value per share, authorized 1,000,000 shares; none issued or outstanding	0	0
Common stock—$1 par value per share, authorized 300,000,000 shares; issued and outstanding 112,090,000 and 111,140,000 shares at January 3, 2021 and December 29, 2019, respectively	112,090	111,140
Capital in excess of par value	148,101	90,357
Retained earnings	3,507,262	2,811,973
Accumulated other comprehensive loss	(31,961)	(199,646)
Total stockholders' equity	3,735,492	2,813,824
Total liabilities and stockholders' equity	$ 7,960,315	$ 6,538,564